TwoStep Therapeutics, a biotechnology company developing innovative, first-in-class, multispecific targeted peptide conjugate therapies for solid tumors, will be presenting at the 2025 PEGS Boston Summit taking place in Boston, Massachusetts on May 13, 2025.
Oral Presentation:
Title: Expanding the Reach of Targeted Cancer Therapy Using Multispecific Peptide-Drug Conjugates
Date and Time: Tuesday, May 13, 2025, at 9:35 a.m. ET
Invited Speaker: Caitlyn Miller, PhD, CEO & Co-Founder of TwoStep Therapeutics
TwoStep Therapeutics is a Stanford University spin-out launched in 2024, co-founded by Nobel Prize winner Carolyn Bertozzi, Jennifer Cochran, Ron Levy, and Caitlyn Miller. This presentation will highlight the outstanding preclinical efficacy and safety of TwoStep’s lead tumor-targeted drug conjugate.
About TwoStep Therapeutics
TwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors. This multi-targeting feature enables the agent’s broad applicability to a wide range of tumor types and patient populations, overcoming the limitations of single-antigen targeting approaches. The company has leveraged this technology to create a pipeline of targeted cancer therapies for cytotoxic drug delivery and radioligand therapy.
More information: https://twosteptx.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513380659/en/
